Takara Bio (Germany) Performance
| TF2 Stock | EUR 6.10 0.25 4.27% |
On a scale of 0 to 100, Takara Bio holds a performance score of 12. The entity has a beta of -0.66, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Takara Bio are expected to decrease at a much lower rate. During the bear market, Takara Bio is likely to outperform the market. Please check Takara Bio's jensen alpha, sortino ratio, maximum drawdown, as well as the relationship between the total risk alpha and treynor ratio , to make a quick decision on whether Takara Bio's existing price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Takara Bio are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, Takara Bio reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0173 | Payout Ratio 1.9653 | Last Split Factor 400:1 | Forward Dividend Rate 0.1 | Ex Dividend Date 2026-03-30 |
Takara |
Takara Bio Relative Risk vs. Return Landscape
If you would invest 426.00 in Takara Bio on November 21, 2025 and sell it today you would earn a total of 184.00 from holding Takara Bio or generate 43.19% return on investment over 90 days. Takara Bio is currently producing 0.7054% returns and takes up 4.6374% volatility of returns over 90 trading days. Put another way, 41% of traded stocks are less volatile than Takara, and 86% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Takara Bio Target Price Odds to finish over Current Price
The tendency of Takara Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 6.10 | 90 days | 6.10 | near 1 |
Based on a normal probability distribution, the odds of Takara Bio to move above the current price in 90 days from now is near 1 (This Takara Bio probability density function shows the probability of Takara Stock to fall within a particular range of prices over 90 days) .
Takara Bio Price Density |
| Price |
Predictive Modules for Takara Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Takara Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Takara Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Takara Bio is not an exception. The market had few large corrections towards the Takara Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Takara Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Takara Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.65 | |
β | Beta against Dow Jones | -0.66 | |
σ | Overall volatility | 0.39 | |
Ir | Information ratio | 0.13 |
Takara Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Takara Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Takara Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Takara Bio appears to be risky and price may revert if volatility continues | |
| About 62.0% of the company outstanding shares are owned by corporate insiders |
Takara Bio Fundamentals Growth
Takara Stock prices reflect investors' perceptions of the future prospects and financial health of Takara Bio, and Takara Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Takara Stock performance.
| Return On Equity | -0.068 | ||||
| Return On Asset | -0.0053 | ||||
| Profit Margin | (0.16) % | ||||
| Operating Margin | (0.26) % | ||||
| Current Valuation | 577.07 M | ||||
| Shares Outstanding | 120.42 M | ||||
| Price To Earning | 52.31 X | ||||
| Price To Book | 1.08 X | ||||
| Price To Sales | 0.02 X | ||||
| Revenue | 45.04 B | ||||
| Gross Profit | 23.84 B | ||||
| EBITDA | 3.98 B | ||||
| Net Income | 1.04 B | ||||
| Cash And Equivalents | 31.49 B | ||||
| Cash Per Share | 261.48 X | ||||
| Total Debt | 9.49 B | ||||
| Debt To Equity | 0.02 % | ||||
| Book Value Per Share | 4.62 X | ||||
| Cash Flow From Operations | 5.84 B | ||||
| Earnings Per Share | (0.29) X | ||||
| Total Asset | 125.33 B | ||||
| Retained Earnings | 52.47 B | ||||
About Takara Bio Performance
By analyzing Takara Bio's fundamental ratios, stakeholders can gain valuable insights into Takara Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Takara Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Takara Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Takara Bio Inc., together with its subsidiaries, operates as a biotechnology company in Japan, the United States, China, other Asia, Europe, and internationally. The company was founded in 2002 and is headquartered in Kusatsu, Japan. TAKARA BIO is traded on Frankfurt Stock Exchange in Germany.Things to note about Takara Bio performance evaluation
Checking the ongoing alerts about Takara Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Takara Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Takara Bio appears to be risky and price may revert if volatility continues | |
| About 62.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Takara Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Takara Bio's stock is overvalued or undervalued compared to its peers.
- Examining Takara Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Takara Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Takara Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Takara Bio's stock. These opinions can provide insight into Takara Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Takara Stock analysis
When running Takara Bio's price analysis, check to measure Takara Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takara Bio is operating at the current time. Most of Takara Bio's value examination focuses on studying past and present price action to predict the probability of Takara Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takara Bio's price. Additionally, you may evaluate how the addition of Takara Bio to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |